CrystalRG, JaffeA, BrodyS, et al.A Phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Hum Gene Ther, 1995; 6:643–666.
2.
LemarchandP, JaffeHA, DanelC, et al.Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci U S A, 1992; 89:6482–6486.
3.
CrystalRG, McElvaneyNG, RosenfeldMA, et al.Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet, 1994; 8:42–51.
4.
FlotteTR, AfioneSA, ConradC, et al.Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci U S A, 1993; 90:10613–10617.
5.
FlotteT, CarterB, ConradC, et al.A Phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther, 1996; 7:1145–1159.
6.
FarrowN, DonnelleyM, CmielewskiP, et al.Role of basal cells in producing persistent lentivirus-mediated airway gene expression. Hum Gene Ther, 2018 [Epub ahead of print]; DOI: 10.1089/hum.2017.059.
7.
CaoH, OuyangH, GrasemannH, et al.Transducing airway basal cells with a helper-dependent adenoviral vector for lung gene therapy. Hum Gene Ther, 2018 [Epub ahead of print]; DOI: 10.1089/hum.2017.201.
